Mylan Inc. said Monday it purchased the rights to produce two products from Valeant Pharmaceuticals International Inc. Canonsburg-based Mylan said it acquired Clindamycin Phosphate/Benzoyl Peroxide gel, the generic version of BenzaClin.
Mylan also reached a licensing agreement to make Fluorouracil cream, the generic version of Valeant's Efudex. Terms were not released.
Clindamycin Phosphate/Benzoyl Peroxide gel, which is used to treat acne, had sales of about $205 million in 2011. Fluorouracil cream, used to treat sun-damaged skin, had sales of about $79 million last year.
